63 -6 (80) 2025 - Gubaydulina G.R. - HIV AND HERPETIC INFECTIONS: CLINICAL AND IMMUNOLOGICAL LABORATORY

HIV AND HERPETIC INFECTIONS: CLINICAL AND IMMUNOLOGICAL LABORATORY

Gubaydulina G.R. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Human Immunodeficiency Virus (HIV) infection is associated with progressive immune system deterioration, resulting in increased susceptibility to opportunistic infections, including herpesviruses. This article reviews the clinical manifestations and immunological-laboratory profiles of herpetic infections in HIV-infected individuals, with particular attention to the mutual influence of these pathogens on the immune system. Herpetic infections, particularly those caused by Herpes Simplex Virus type 1 and 2 (HSV-1, HSV-2), are common among individuals with Human Immunodeficiency Virus (HIV). Co-infection can significantly impact disease progression, clinical management, and patient outcomes. This article explores the pathophysiological interactions between HIV and herpetic viruses, highlights clinical implications, and discusses therapeutic approaches to managing co-infected patients

Keywords: HIV, herpes simplex virus, varicella-zoster virus, immunodeficiency, CD4+, cytokines, opportunistic infections

First page

319

Last page

322

For citation:Gubaydulina G.R. - HIV AND HERPETIC INFECTIONS: CLINICAL AND IMMUNOLOGICAL LABORATORY//New Day in Medicine 6(80)2025 319-322 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

  1. Corey, L., & Wald, A. (2009). Genital herpes. Infectious Disease Clinics of North America, 23(4), 825–839. https://doi.org/10.1016/j.idc.2009.07.004
  2. Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., & Hayes, R. J. (2006). Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS, 20(1), 73–83. https://doi.org/10.1097/01.aids.0000198081.09378.eb
  3. Looker, K. J., Magaret, A. S., May, M. T., Turner, K. M., Vickerman, P., Newman, L. M., & Gottlieb, S. L. (2015). Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS ONE, 10(10), e0140765. https://doi.org/10.1371/journal.pone.0140765
  4. Patel, P., Klausner, J. D., & Kojima, N. (2017). The role of herpes simplex virus type 2 infection in facilitating HIV acquisition and transmission: A review. Sexually Transmitted Diseases, 44(4), 211–218. https://doi.org/10.1097/OLQ.0000000000000563
  5. Whitley, R. J., & Baines, J. D. (2018). Herpes simplex viruses. Clinical Virology, 325–342. https://doi.org/10.1016/B978-0-12-814515-9.00016-4
  6. Schacker, T., Ryncarz, A. J., Goddard, J., Diem, K., Shaughnessy, M., & Corey, L. (1998). Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1–infected men. JAMA, 280(1), 61–66. https://doi.org/10.1001/jama.280.1.61
  7. Wald, A., Link, K., & Ashley-Morrow, R. (2008). Impact of herpes simplex virus type 2 infection on HIV acquisition and transmission. Journal of Infectious Diseases, 197(Supplement_3), S179–S185. https://doi.org/10.1086/533591
  8. Zhu, J., Hladik, F., Woodward, A., Klock, A., Peng, T., Johnston, C & Corey, L. (2009). Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nature Medicine, 15(8), 886–892. https://doi.org/10.1038/nm.1993
  9. Lisco, A., Vanpouille, C., Margolis, L. (2013). HSV, HIV and drug abuse: A three-way synergy. Trends in Microbiology, 21(8), 397–404. https://doi.org/10.1016/j.tim.2013.06.006
  10. Koelle, D. M., & Corey, L. (2008). Herpes simplex: Insights on pathogenesis and possible vaccines. 59, 381–395. https://doi.org/10.1146/annurev.med.59.053006.104535

    file

    download